138
Views
21
CrossRef citations to date
0
Altmetric
Review

Mechanisms of T-cell inhibition: implications for cancer immunotherapy

&
Pages 89-105 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Dandan Chen, Ping Tang, Linxiang Liu, Fang Wang, Haizhou Xing, Ling Sun & Zhongxing Jiang. (2018) Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway. Cell Cycle 17:7, pages 858-867.
Read now
Andrés A. Herrada, Nicole Rojas-Colonelli, Paula González-Figueroa, Jonathan Roco, César Oyarce, Maarten A Ligtenberg & Alvaro Lladser. (2012) Harnessing DNA-induced immune responses for improving cancer vaccines. Human Vaccines & Immunotherapeutics 8:11, pages 1682-1693.
Read now
Diane F Hale, G Travis Clifton, Alan K Sears, Timothy J Vreeland, Nathan Shumway, George E Peoples & Elizabeth A Mittendorf. (2012) Cancer vaccines: should we be targeting patients with less aggressive disease?. Expert Review of Vaccines 11:6, pages 721-731.
Read now
Elizabeth A Mittendorf, Gheath Alatrash, Haile Xiao, G Travis Clifton, James L Murray & George E Peoples. (2011) Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials. Expert Review of Vaccines 10:6, pages 755-774.
Read now

Articles from other publishers (17)

Theresa L. Whiteside. 2022. Interaction of Immune and Cancer Cells. Interaction of Immune and Cancer Cells 89 106 .
Z Liu, F Mi, M Han, M Tian, L Deng, N Meng, J Luo & R Fu. (2021) Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma. Clinical and Experimental Immunology 205:1, pages 53-62.
Crossref
Kwang-Min Kim, Hyang Suk Choi, Hany Noh, In-Jeong Cho, Seung Taek Lim, Jong-In Lee & Airi Han. (2021) Neutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer. Journal of Breast Cancer 24:5, pages 443.
Crossref
Akhil Chawla, Gheath Alatrash, Anne V. Philips, Na Qiao, Pariya Sukhumalchandra, Celine Kerros, Iulia Diaconu, Victor Gall, Samantha Neal, Haley L. Peters, Karen Clise-Dwyer, Jeffrey J. Molldrem & Elizabeth A. Mittendorf. (2016) Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells. Cancer Immunology, Immunotherapy 65:6, pages 741-751.
Crossref
Caroline J Breitbach, Kelley Parato, James Burke, Tae-Ho Hwang, John C Bell & David H Kirn. (2015) Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic. Current Opinion in Virology 13, pages 49-54.
Crossref
Fnu Apoorva & Ankur Singh. 2015. Biomaterials in Regenerative Medicine and the Immune System. Biomaterials in Regenerative Medicine and the Immune System 171 192 .
Ying Zhang & Hildegund C. J. Ertl. (2014) The Effect of Adjuvanting Cancer Vaccines with Herpes Simplex Virus Glycoprotein D on Melanoma-Driven CD8+ T Cell Exhaustion. The Journal of Immunology 193:4, pages 1836-1846.
Crossref
Chelsea M. Black, Todd D. Armstrong & Elizabeth M. Jaffee. (2014) Apoptosis-Regulated Low-Avidity Cancer-Specific CD8+ T Cells Can Be Rescued to Eliminate HER2/neu–Expressing Tumors by Costimulatory Agonists in Tolerized Mice. Cancer Immunology Research 2:4, pages 307-319.
Crossref
Theresa L. Whiteside. 2014. Interaction of Immune and Cancer Cells. Interaction of Immune and Cancer Cells 111 121 .
Akhil Chawla, Gheath Alatrash, Yun Wu & Elizabeth A Mittendorf. (2013) Immune aspects of the breast tumor microenvironment. Breast Cancer Management 2:3, pages 231-244.
Crossref
Eric Jonasch, P. Andrew Futreal, Ian J. Davis, Sean T. Bailey, William Y. Kim, James Brugarolas, Amato J. Giaccia, Ghada Kurban, Armin Pause, Judith Frydman, Amado J. Zurita, Brian I. Rini, Pam Sharma, Michael B. Atkins, Cheryl L. Walker & W. Kimryn Rathmell. (2012) State of the Science: An Update on Renal Cell Carcinoma. Molecular Cancer Research 10:7, pages 859-880.
Crossref
Eddie Thara, Tanya B. Dorff, Monica Averia-Suboc, Michael Luther, Mary E. Reed, Jacek K. Pinski & David I. Quinn. (2012) Immune Response to Sipuleucel-T in Prostate Cancer. Cancers 4:2, pages 420-441.
Crossref
Vivian L. Weiss, Timothy H. Lee, Hong Song, Theodore S. Kouo, Chelsea M. Black, George Sgouros, Elizabeth M. Jaffee & Todd D. Armstrong. (2012) Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells. PLoS ONE 7:2, pages e31962.
Crossref
Caitlin D. Lemke, Jessica B. Graham, Sean M. Geary, Gideon Zamba, David M. Lubaroff & Aliasger K. Salem. (2011) Chitosan Is a Surprising Negative Modulator of Cytotoxic CD8 + T Cell Responses Elicited by Adenovirus Cancer Vaccines . Molecular Pharmaceutics 8:5, pages 1652-1661.
Crossref
Aimee E. Hammerstrom, Diana H. Cauley, Bradley J. Atkinson & Padmanee Sharma. (2012) Cancer Immunotherapy: Sipuleucel‐T and Beyond. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:8, pages 813-828.
Crossref
C. Ma & X. Dong. (2011) Colorectal Cancer–Derived Foxp3 + IL‐17 + T Cells Suppress Tumour‐Specific CD8 + T Cells . Scandinavian Journal of Immunology 74:1, pages 47-51.
Crossref
Alvaro Lladser, Carlos Sanhueza, Rolf Kiessling & Andrew F.G. Quest. 2011. 1 37 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.